Inventor · disambiguated record
Peter J. Connolly
Also filed as: CONNOLLY PETER · CONNOLLY PETER J
67 granted patents·19 pending applications·787 citations·filing 1991–2023
99Inventor score
Files withJANSSEN PHARMACEUTICA NV41CONNOLLY PETER J11JANSSEN BIOTECH INC8ORTHO MCNEIL PHARM INC7ORTHO PHARMA CORP6
Top patents by PatentIndex Score
86 records- 0198US6750369B2Substituted amino acids as erythropoietin mimeticsORTHO MCNEIL PHARM INC·Filed 2001·Granted Jun 15, 2004·155 cites·17 claims
- 0298US6310078B1Substituted amino acids as erythropoietin mimeticsORTHO MCNEIL PHARM INC·Filed 2000·Granted Oct 30, 2001·179 cites·4 claims
- 0397US8759333B2Di-azetidinyl diamide as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jun 24, 2014·45 cites·2 claims
- 0496US7541367B23-benzoimidazolyl-pyrazolopyridines useful in treating kinase disordersJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Jun 2, 2009·104 cites·38 claims
- 0592US8685990B2Pyrimidine compounds as delta opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 1, 2014·19 cites·3 claims
- 0690US10954214B2Pyrazole derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Mar 23, 2021·5 cites·37 claims
- 0789US7855205B2Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disordersJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Dec 21, 2010·9 cites·88 claims
- 0887US8748417B2Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jun 10, 2014·9 cites·2 claims
- 0986US10077261B2Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancerJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Sep 18, 2018·7 cites·16 claims
- 1086US7317031B2Substituted triazole diamine derivatives as kinase inhibitorsORTHO MCNEIL PHARM INC·Filed 2005·Granted Jan 8, 2008·5 cites·11 claims
- 1185US8513423B2Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitorsCONNOLLY PETER J·Filed 2011·Granted Aug 20, 2013·8 cites·16 claims
- 1284US7582649B2Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disordersJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Sep 1, 2009·7 cites·14 claims
- 1384US6710048B2Pyrazine derivatives as modulators of tyrosine kinasesORTHO MCNEIL PHARM INC·Filed 2001·Granted Mar 23, 2004·25 cites·71 claims
- 1483US7579356B2Thia-tetraazaacenaphthylene kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Aug 25, 2009·9 cites·27 claims
- 1583US6924302B2Substituted triazole diamine derivatives as kinase inhibitorsORTHO MCNEIL PHARM INC·Filed 2001·Granted Aug 2, 2005·21 cites·12 claims
- 1682US8846655B24-substituted-2-phenoxy-phenylamine delta opioid receptor modulatorsCOATS STEVEN J·Filed 2010·Granted Sep 30, 2014·7 cites·24 claims
- 1782US8013153B2Substituted pyrimidine kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Sep 6, 2011·14 cites·18 claims
- 1882US7655670B23-spirocyclic indolyl derivatives useful as ORL-1 receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Feb 2, 2010·8 cites·4 claims
- 1982US6828327B2Macroheterocylic compounds useful as kinase inhibitorsORTHO MCNEIL PHARM INC·Filed 2001·Granted Dec 7, 2004·18 cites·5 claims
- 2081US8722658B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted May 13, 2014·2 cites·4 claims
- 2181US8697683B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 15, 2014·2 cites·4 claims
- 2280US10888550B2Pyrazole derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jan 12, 2021·3 cites·10 claims
- 2380US8962607B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Feb 24, 2015·2 cites·9 claims
- 2479US7081463B2Hydroxy alkyl substituted 1,3,8-Triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disordersJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Jul 25, 2006·11 cites·15 claims
- 2578US5387693ATetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole intermediate compoundsORTHO PHARMA CORP·Filed 1993·Granted Feb 7, 1995·17 cites·1 claims
- 2676US11040031B2Pyrazole derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jun 22, 2021·2 cites·9 claims
- 2775US8153791B2Substituted pyrimidinyl oxime kinase inhibitorsXU GUOZHANG·Filed 2006·Granted Apr 10, 2012·5 cites·24 claims
- 2875US7888380B21,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivativesJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Feb 15, 2011·2 cites·27 claims
- 2975US6028202A1,5-diarylpyrazolesORTHO PHARMA CORP·Filed 1998·Granted Feb 22, 2000·16 cites·2 claims
- 3074US11597746B2Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2019·Granted Mar 7, 2023·1 cites·53 claims
- 3174US8183371B2Pyrazines as delta opioid receptor modulatorsCONNOLLY PETER J·Filed 2010·Granted May 22, 2012·2 cites·17 claims
- 3274US5134155ATetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-coA reductase inhibitorsORTHO PHARMA CORP·Filed 1991·Granted Jul 28, 1992·25 cites·11 claims
- 3373US10501469B2Substituted thiohydantoin derivatives as androgen receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Dec 10, 2019·1 cites·53 claims
- 3473US5925769AAcetylenic 1,5-diarylpyrazoles as antiinflammatory agentsORTHO PHARMA CORP·Filed 1998·Granted Jul 20, 1999·15 cites·16 claims
- 3573US2023287034A1Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 3672US8759533B2Di-azetidinyl diamide as monoacylglcerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jun 24, 2014·1 cites·12 claims
- 3772US8637498B2Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitorsCONNOLLY PETER J·Filed 2011·Granted Jan 28, 2014·2 cites·30 claims
- 3871US7605154B2Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Oct 20, 2009·2 cites·5 claims
- 3971US2023144627A1Cyclic Dinucleotides As Sting AgonistsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 4069US9562035B2Benzamide derivative useful as FASN inhibitors for the treatment of cancerJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Feb 7, 2017·1 cites·23 claims
- 4168US5315012ATetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compoundsORTHO PHARMA CORP·Filed 1993·Granted May 24, 1994·17 cites·1 claims
- 4267US10981926B2Substituted thiohydantoin derivatives as androgen receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Apr 20, 2021·0 cites·51 claims
- 4367US8778956B2Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disordersBATTISTA KATHLEEN·Filed 2008·Granted Jul 15, 2014·1 cites·15 claims
- 4467US2023146410A1Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 4564US12077521B2Pyrazole derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Sep 3, 2024·0 cites·18 claims
- 4664US8575363B2Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitorsZHANG YUE-MEI·Filed 2011·Granted Nov 5, 2013·1 cites·10 claims
- 4760US7427625B2Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Sep 23, 2008·0 cites·19 claims
- 4860US2008300264A1Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitorsCONNOLLY PETER J·Filed 2008·Application pending·0 cites
- 4960US2019337924A1Substituted hydantoin and thiohydantoin derivatives as androgen receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 5059US11492367B2Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2018·Granted Nov 8, 2022·0 cites·19 claims
Showing the top 50 of 86 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Peter J. Connolly files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →